Adagene, Sanofi signs collaboration and license deal worth up to $2.5bn
Adagene, a US-based biopharma company, has signed a collaboration and license deal worth up to $2.5 billion plus royalties with Sanofi to produce masked monoclonal and bispecific immuno-oncology antibody candidates for development and commercialization by the latter. As per the terms of the deal, Adagene will handle the early stage research activities for developing masked […]